Literature DB >> 12449429

Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia.

J Novotná1, J Herget.   

Abstract

Exposure to chronic hypoxia results in hypoxic pulmonary hypertension characterized by structural remodeling of peripheral pulmonary vasculature. An important part of this remodeling is an increase of collagen turnover and deposition of newly formed collagen fibrils in the vascular walls. The activity of collagenolytic metalloproteinases in the lung tissue is notably increased in the first days of exposure to hypoxia. The increased collagenolytic activity results in the appearance of collagen cleavages, which may be implied in the triggering of mesenchymal proliferation in peripheral pulmonary arteries. We hypothesize that radical injury to pulmonary vascular walls is involved in collagenolytic metalloproteinase activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12449429

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  7 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

2.  Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats.

Authors:  Ludek Vajner; Richard Vytásek; Vera Lachmanová; Jirí Uhlík; Václava Konrádová; Jana Novotná; Václav Hampl; Jan Herget
Journal:  Int J Exp Pathol       Date:  2006-10       Impact factor: 1.925

3.  Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice.

Authors:  Joseph George; Jie Sun; Jeanine D'Armiento
Journal:  Clin Sci (Lond)       Date:  2012-01       Impact factor: 6.124

4.  Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats.

Authors:  Xue-qin Li; Han-ming Wang; Chun-guang Yang; Xin-hua Zhang; Dan-dan Han; Huai-liang Wang
Journal:  Acta Pharmacol Sin       Date:  2011-01-10       Impact factor: 6.150

5.  Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice.

Authors:  Joseph George; Jeanine D'Armiento
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

6.  Decreased collagen VI in the tunica media of pulmonary vessels during exposure to hypoxia: a novel step in pulmonary arterial remodeling.

Authors:  Marie Žaloudíková; Adam Eckhardt; Richard Vytášek; Jiří Uhlík; Tomáš Novotný; Lucie Bačáková; Jana Musílková; Václav Hampl
Journal:  Pulm Circ       Date:  2019 Jul-Sep       Impact factor: 3.017

7.  Inhibitory effects of formononetin on the monocrotaline‑induced pulmonary arterial hypertension in rats.

Authors:  Yonghui Wu; Changhong Cai; Lebing Yang; Yijia Xiang; Huan Zhao; Chunlai Zeng
Journal:  Mol Med Rep       Date:  2020-01-03       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.